Institute for Myeloma Bone Cancer Research

The Institute for Myeloma & Bone Cancer Research, headquartered in West Hollywood, California, is a research organization dedicated to improving treatments for multiple myeloma and other bone cancers. Employing 18 individuals, IMBCR focuses on providing holistic patient care, recognizing that treatment extends beyond medication. IMBCR's core mission revolves around exploring innovative drug combinations, leveraging both existing and novel therapies, to optimize patient outcomes. Their collaborative approach involves partnerships with leading institutions and centers of excellence globally, ensuring access to cutting-edge advancements in myeloma treatment. IMBCR distinguishes itself through its patient-centric philosophy, prioritizing individualized care plans tailored to each patient's unique needs. Their commitment to scientific innovation drives the pursuit of personalized and continuously optimized patient care, ultimately aiming to advance the treatment landscape for myeloma. For more information about IMBCR's research, programs, and patient resources, please visit their website at imbcr.org.